nach oben

Osteoporosis International

Erschienen in:

21.01.2021 | COVID-19 | Letter to the Editor Zur Zeit gratis

RETRACTED ARTICLE: Comment on an article: “Osteoporosis in the age of COVID-19 patients”

verfasst von: O. Ć. Ibrahimagić, A. Vujadinović, Z. Ercegović, S. Kunić, Dž. Smajlović, Z. Dostović

Erschienen in: Osteoporosis International | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear Co-editors-in-Chief Kanis and Cosman, …

Girgis CM, Clifton-Bligh RJ (2020) Osteoporosis in the age of COVID-19. Osteoporos Int 31(7):1189–1191. https://doi.org/10.1007/s00198-020-05413-0CrossRefPubMedPubMedCentral

Aspray TJ, Hill TR (2019) Osteoporosis and the ageing skeleton. Subcell Biochem 91:453–476. https://doi.org/10.1007/978-981-13-3681-2-16CrossRefPubMed

Duncan R, Francis RM, Jagger C, Kingston A, McCloskey E, Collerton J et al (2015) Magnitude of fragility risk in the very old-are we meeting their needs? The Newcastle 85+ Study. Osteoporos Int 26(1):123–130. https://doi.org/10.1007/s00198-0124-2837-8CrossRefPubMed

Saito M, Marumo K (2018) The effects of homocysteine on the skeleton. Curr Osteporos Rep 16(5):554–560. https://doi.org/10.1007/s11914-018-0469-1CrossRef

Azzini E, Ruggeri S, Polito A (2020) Homocysteine: its possible emerging role in at-risk population groups. Int J Mol Sci 21(4):1421. https://doi.org/10.3390/ijms21041421CrossRefPubMedCentral

B-Vitamin Treatment Trialists’ Collaboration (2006) Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J 151(2):282–287. https://doi.org/10.1016/j.ahj.2005.04.025CrossRef

Ibrahimagić OĆ, Smajlović D, Dostović Z, Pašić Z, Šehanović A, Hodžić R (2012) Hyperhomocysteinemia and its treatment in patients with ischemic stroke. Medicus 21(2):267–272

Ibrahimagić OĆ, Smajlović D, Dostović Z, Pašić Z, Kunić S, Iljazović A et al (2016) Hyperhomocysteinemia and its treatment in patients with Parkinson’s disease. Mater Soc 28(4):303–306. https://doi.org/10.5455/msm.2016.28.303-306CrossRef

Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R et al (2010) Hyperhomocysteinemia recurrence in levodopa-treated Parkinson’s disease patients. Eur J Neurol 17(5):661–615. https://doi.org/10.1111/j.1468-1331.2009.02984.xCrossRefPubMed

10.

Tan SHS, Hong CC, Saha S, Murphy D, Hui JH (2020) Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective. Int Orthop (SICOT) 44(8):1599–1603. https://doi.org/10.1007/s00264-020-04643-5CrossRef

Titel: RETRACTED ARTICLE: Comment on an article: “Osteoporosis in the age of COVID-19 patients”
verfasst von: O. Ć. Ibrahimagić
A. Vujadinović
Z. Ercegović
S. Kunić
Dž. Smajlović
Z. Dostović
Publikationsdatum: 21.01.2021
Verlag: Springer London
Schlagwort: COVID-19
Erschienen in: Osteoporosis International / Ausgabe 4/2021
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05607-6

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

16.04.2024 | Spondylitis ankylosans | Nachrichten

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

weitere anzeigen

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2021

Correction to: Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use

How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey

Postpartum bilateral sacral stress fracture without osteoporosis—a case report and literature review

Correction to: Bisphosphonates and mortality: confounding in observational studies

Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion

Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophosphatemic rickets